| Outcomes of treatment for hepatitis C in primary care, compared to hospital-based care: a randomized, controlled trial in people who inject drugs AJ Wade, JS Doyle, E Gane, C Stedman, B Draper, D Iser, SK Roberts, ... Clinical Infectious Diseases 70 (9), 1900-1906, 2020 | 94 | 2020 |
| Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review JC Cutts, PA Agius, Z Lin, R Powell, K Moore, B Draper, JA Simpson, ... BMC medicine 18, 1-21, 2020 | 65 | 2020 |
| Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study B Williams, J Howell, J Doyle, AJ Thompson, B Draper, C Layton, ... International Journal of Drug Policy 72, 91-98, 2019 | 51 | 2019 |
| Achieving development goals for HIV, tuberculosis and malaria in sub-Saharan Africa through integrated antenatal care: barriers and challenges FJI Fowkes, BL Draper, M Hellard, M Stoové BMC medicine 14, 1-10, 2016 | 48 | 2016 |
| Outcomes of the CT2 study: A ‘one‐stop‐shop’for community‐based hepatitis C testing and treatment in Yangon, Myanmar BL Draper, H Htay, A Pedrana, WL Yee, J Howell, K Pyone Kyi, W Naing, ... Liver International 41 (11), 2578-2589, 2021 | 38 | 2021 |
| Willingness to use HIV pre‐exposure prophylaxis among gay men, other men who have sex with men and transgender women in Myanmar BL Draper, ZM Oo, ZW Thein, PP Aung, V Veronese, C Ryan, M Thant, ... Journal of the International AIDS Society 20 (1), 21885, 2017 | 36 | 2017 |
| Does training people to administer take‐home naloxone increase their knowledge? Evidence from Australian programs PM Dietze, B Draper, A Olsen, KJ Chronister, I van Beek, N Lintzeris, ... Drug and alcohol review 37 (4), 472-479, 2018 | 34 | 2018 |
| Comfort relying on HIV pre-exposure prophylaxis and treatment as prevention for condomless sex: results of an online survey of Australian gay and bisexual men M Holt, BL Draper, AE Pedrana, AL Wilkinson, M Stoové AIDS and Behavior 22, 3617-3626, 2018 | 32 | 2018 |
| A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment AY Palmer, AJ Wade, B Draper, J Howell, JS Doyle, D Petrie, ... International Journal of Drug Policy 76, 102633, 2020 | 25 | 2020 |
| Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients B Draper, WL Yee, A Pedrana, KP Kyi, H Qureshi, H Htay, W Naing, ... The Lancet Regional Health–Western Pacific 20, 2022 | 24 | 2022 |
| A survey of hepatitis C management by Victorian GPs after PBS-listing of direct-acting antiviral therapy A Wade, B Draper, J Doyle, N Allard, P Grinzi, A Thompson, M Hellard Australian family physician 46 (4), 235-240, 2017 | 24 | 2017 |
| Acceptability of peer-delivered HIV testing and counselling among men who have sex with men (MSM) and transgender women (TW) in Myanmar V Veronese, ZM Oo, ZW Thein, PP Aung, BL Draper, C Hughes, C Ryan, ... AIDS and Behavior 22, 2426-2434, 2018 | 18 | 2018 |
| Measuring and understanding the attitudes of Australian gay and bisexual men towards biomedical HIV prevention using cross-sectional data and factor analyses AL Wilkinson, BL Draper, AE Pedrana, J Asselin, M Holt, ME Hellard, ... Sexually transmitted infections 94 (4), 309-314, 2018 | 15 | 2018 |
| The impact of point‐of‐care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian … J Howell, MW Traeger, B Williams, C Layton, JS Doyle, N Latham, ... Journal of Viral Hepatitis 29 (5), 375-384, 2022 | 13 | 2022 |
| Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar … BL Draper, A Pedrana, J Howell, WL Yee, H Htay, KS Aung, S Shilton, ... JMIR Research Protocols 9 (7), e16863, 2020 | 11 | 2020 |
| Eliminating hepatitis C Part 1. Finding your patients with hepatitis C B Draper, C Layton, J Doyle, J Howell, D Baker, M Stoové, A Pedrana Medicine Today 20 (6), 34-40, 2019 | 11 | 2019 |
| Health service utilization and experiences of stigma amongst people who inject drugs in Melbourne, Australia F Djordjevic, K Ryan, J Gunn, L Brener, D O’Keefe, B Draper, S Schroeder, ... Journal of Viral Hepatitis 28 (12), 1738-1743, 2021 | 10 | 2021 |
| Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits N Scott, TM Win, T Tidhar, H Htay, B Draper, PTZ Aung, Y Xiao, A Bowring, ... The Lancet Regional Health–Western Pacific 10, 2021 | 10 | 2021 |
| Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial AJ Wade, JS Doyle, E Gane, C Stedman, B Draper, D Iser, SK Roberts, ... Trials 19, 1-9, 2018 | 10 | 2018 |
| Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up BL Draper, WL Yee, S Shilton, A Bowring, H Htay, N Nwe, J Markby, ... BMJ open 12 (5), e059639, 2022 | 6 | 2022 |
